Industry: Medical Devices & Consumables
Published Date: 2025-02-14
Pages: 80 Pages
Report ld: 3893124
Request Sample
Customized Report
Implantable Neurostimulation System Market Size(US$)

CAGR 2025-2031
10.2%
Market Size,2031
USD 11,700
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Implantable Neurostimulation System market size was US$ 5986 million in 2024 and is forecast to a readjusted size of US$ 11700 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Neurostimulation Systems are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.
The Implantable Neurostimulation System market is primarily driven by the rising prevalence of neurological disorders such as Parkinson's disease, epilepsy, chronic pain, and depression. As the global population ages, the incidence of these chronic conditions is increasing, creating a growing demand for effective and long-term treatment options. I Implantable Neurostimulation System offer a promising solution for managing symptoms of these conditions, particularly for patients who have not responded to conventional therapies. Technological advancements in neurostimulation devices, such as more refined targeting mechanisms, smaller device sizes, and enhanced patient control, are also fueling market growth by improving treatment outcomes and patient satisfaction.
However, the market faces several challenges, including the high cost of implantable devices and the associated surgical procedures. These costs can limit accessibility, especially in low- and middle-income countries or healthcare systems with budget constraints. Additionally, while neurostimulators have shown positive results in treating various conditions, concerns remain regarding the long-term effectiveness, potential side effects, and device-related complications, such as battery life and the need for device replacements. The complexity of implantation and post-operative care also presents challenges for healthcare providers, requiring specialized training and resources, which may hinder broader adoption.
North America is the largest sales region of Implantable Neurostimulation System, with market share nearly 42% in 2023. Europe is the second largest sales of Implantable Neurostimulation System, enjoying market share nearly 29% in 2023. Medtronic, Boston Scientific, Abbott, LivaNova are the leading company, with the market share about 90%.
The global Implantable Neurostimulation System market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Implantable Neurostimulation System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Implantable Neurostimulation System in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Implantable Neurostimulation System manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Implantable Neurostimulation System revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Implantable Neurostimulation System Product Scope
1.2 Implantable Neurostimulation System by Type
1.2.1 Global Implantable Neurostimulation System Sales by Type (2020 & 2024 & 2031)
1.2.2 Deep Brain Stimulation (DBS)
1.2.3 Spinal Cord Stimulation (SCS)
1.2.4 Vagus Nerve Stimulation (VNS)
1.2.5 Sacral Nerve Stimulation (SNS)
1.2.6 Gastric Electric Stimulation (GES)
1.2.7 Other
1.3 Implantable Neurostimulation System by Application
1.3.1 Global Implantable Neurostimulation System Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospitals & Clinics
1.3.3 Cognitive Care Centers
1.3.4 Research Institutes
1.3.5 Others
1.4 Global Implantable Neurostimulation System Market Estimates and Forecasts (2020-2031)
1.4.1 Global Implantable Neurostimulation System Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Implantable Neurostimulation System Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Implantable Neurostimulation System Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Implantable Neurostimulation System Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Implantable Neurostimulation System Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Implantable Neurostimulation System Sales Market Share by Region (2020-2025)
2.2.2 Global Implantable Neurostimulation System Revenue Market Share by Region (2020-2025)
2.3 Global Implantable Neurostimulation System Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Implantable Neurostimulation System Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Implantable Neurostimulation System Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Implantable Neurostimulation System Market Size and Prospective (2020-2031)
2.4.2 Europe Implantable Neurostimulation System Market Size and Prospective (2020-2031)
2.4.3 China Implantable Neurostimulation System Market Size and Prospective (2020-2031)
2.4.4 Japan Implantable Neurostimulation System Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Implantable Neurostimulation System Historic Market Review by Type (2020-2025)
3.1.1 Global Implantable Neurostimulation System Sales by Type (2020-2025)
3.1.2 Global Implantable Neurostimulation System Revenue by Type (2020-2025)
3.1.3 Global Implantable Neurostimulation System Price by Type (2020-2025)
3.2 Global Implantable Neurostimulation System Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Implantable Neurostimulation System Sales Forecast by Type (2026-2031)
3.2.2 Global Implantable Neurostimulation System Revenue Forecast by Type (2026-2031)
3.2.3 Global Implantable Neurostimulation System Price Forecast by Type (2026-2031)
3.3 Different Types Implantable Neurostimulation System Representative Players
4 Global Market Size by Application
4.1 Global Implantable Neurostimulation System Historic Market Review by Application (2020-2025)
4.1.1 Global Implantable Neurostimulation System Sales by Application (2020-2025)
4.1.2 Global Implantable Neurostimulation System Revenue by Application (2020-2025)
4.1.3 Global Implantable Neurostimulation System Price by Application (2020-2025)
4.2 Global Implantable Neurostimulation System Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Implantable Neurostimulation System Sales Forecast by Application (2026-2031)
4.2.2 Global Implantable Neurostimulation System Revenue Forecast by Application (2026-2031)
4.2.3 Global Implantable Neurostimulation System Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Implantable Neurostimulation System Application
5 Competition Landscape by Players
5.1 Global Implantable Neurostimulation System Sales by Players (2020-2025)
5.2 Global Top Implantable Neurostimulation System Players by Revenue (2020-2025)
5.3 Global Implantable Neurostimulation System Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Neurostimulation System as of 2024)
5.4 Global Implantable Neurostimulation System Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Implantable Neurostimulation System, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Implantable Neurostimulation System, Product Type & Application
5.7 Global Key Manufacturers of Implantable Neurostimulation System, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Implantable Neurostimulation System Sales by Company
6.1.1.1 North America Implantable Neurostimulation System Sales by Company (2020-2025)
6.1.1.2 North America Implantable Neurostimulation System Revenue by Company (2020-2025)
6.1.2 North America Implantable Neurostimulation System Sales Breakdown by Type (2020-2025)
6.1.3 North America Implantable Neurostimulation System Sales Breakdown by Application (2020-2025)
6.1.4 North America Implantable Neurostimulation System Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Implantable Neurostimulation System Sales by Company
6.2.1.1 Europe Implantable Neurostimulation System Sales by Company (2020-2025)
6.2.1.2 Europe Implantable Neurostimulation System Revenue by Company (2020-2025)
6.2.2 Europe Implantable Neurostimulation System Sales Breakdown by Type (2020-2025)
6.2.3 Europe Implantable Neurostimulation System Sales Breakdown by Application (2020-2025)
6.2.4 Europe Implantable Neurostimulation System Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Implantable Neurostimulation System Sales by Company
6.3.1.1 China Implantable Neurostimulation System Sales by Company (2020-2025)
6.3.1.2 China Implantable Neurostimulation System Revenue by Company (2020-2025)
6.3.2 China Implantable Neurostimulation System Sales Breakdown by Type (2020-2025)
6.3.3 China Implantable Neurostimulation System Sales Breakdown by Application (2020-2025)
6.3.4 China Implantable Neurostimulation System Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Implantable Neurostimulation System Sales by Company
6.4.1.1 Japan Implantable Neurostimulation System Sales by Company (2020-2025)
6.4.1.2 Japan Implantable Neurostimulation System Revenue by Company (2020-2025)
6.4.2 Japan Implantable Neurostimulation System Sales Breakdown by Type (2020-2025)
6.4.3 Japan Implantable Neurostimulation System Sales Breakdown by Application (2020-2025)
6.4.4 Japan Implantable Neurostimulation System Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Medtronic
7.1.1 Medtronic Company Information
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Implantable Neurostimulation System Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Medtronic Implantable Neurostimulation System Products Offered
7.1.5 Medtronic Recent Development
7.2 Boston Scientific
7.2.1 Boston Scientific Company Information
7.2.2 Boston Scientific Business Overview
7.2.3 Boston Scientific Implantable Neurostimulation System Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Boston Scientific Implantable Neurostimulation System Products Offered
7.2.5 Boston Scientific Recent Development
7.3 Abbott
7.3.1 Abbott Company Information
7.3.2 Abbott Business Overview
7.3.3 Abbott Implantable Neurostimulation System Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Abbott Implantable Neurostimulation System Products Offered
7.3.5 Abbott Recent Development
7.4 LivaNova
7.4.1 LivaNova Company Information
7.4.2 LivaNova Business Overview
7.4.3 LivaNova Implantable Neurostimulation System Sales, Revenue and Gross Margin (2020-2025)
7.4.4 LivaNova Implantable Neurostimulation System Products Offered
7.4.5 LivaNova Recent Development
7.5 Nevro
7.5.1 Nevro Company Information
7.5.2 Nevro Business Overview
7.5.3 Nevro Implantable Neurostimulation System Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Nevro Implantable Neurostimulation System Products Offered
7.5.5 Nevro Recent Development
7.6 Ruishenan Medical
7.6.1 Ruishenan Medical Company Information
7.6.2 Ruishenan Medical Business Overview
7.6.3 Ruishenan Medical Implantable Neurostimulation System Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Ruishenan Medical Implantable Neurostimulation System Products Offered
7.6.5 Ruishenan Medical Recent Development
7.7 Beijing Pins
7.7.1 Beijing Pins Company Information
7.7.2 Beijing Pins Business Overview
7.7.3 Beijing Pins Implantable Neurostimulation System Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Beijing Pins Implantable Neurostimulation System Products Offered
7.7.5 Beijing Pins Recent Development
7.8 Sceneray
7.8.1 Sceneray Company Information
7.8.2 Sceneray Business Overview
7.8.3 Sceneray Implantable Neurostimulation System Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Sceneray Implantable Neurostimulation System Products Offered
7.8.5 Sceneray Recent Development
7.9 Inspire Medical Systems
7.9.1 Inspire Medical Systems Company Information
7.9.2 Inspire Medical Systems Business Overview
7.9.3 Inspire Medical Systems Implantable Neurostimulation System Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Inspire Medical Systems Implantable Neurostimulation System Products Offered
7.9.5 Inspire Medical Systems Recent Development
7.10 Nurotron
7.10.1 Nurotron Company Information
7.10.2 Nurotron Business Overview
7.10.3 Nurotron Implantable Neurostimulation System Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Nurotron Implantable Neurostimulation System Products Offered
7.10.5 Nurotron Recent Development
8 Implantable Neurostimulation System Manufacturing Cost Analysis
8.1 Implantable Neurostimulation System Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Implantable Neurostimulation System
8.4 Implantable Neurostimulation System Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Implantable Neurostimulation System Distributors List
9.3 Implantable Neurostimulation System Customers
10 Implantable Neurostimulation System Market Dynamics
10.1 Implantable Neurostimulation System Industry Trends
10.2 Implantable Neurostimulation System Market Drivers
10.3 Implantable Neurostimulation System Market Challenges
10.4 Implantable Neurostimulation System Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Implantable Neurostimulation System was estimated to be worth US$ 6536 million in 2025 and is projected to reach US$ 12780 million, growing at a CAGR of 10.2% from 2026 to 2032.
Published Date: 2026-02-11
Pages: 91
USD 3950.00
(Single User License)
The global Implantable Neurostimulation System market was valued at US$ 6536 million in 2025 and is anticipated to reach US$ 12780 million by 2032, at a CAGR of 10.2% from 2026 to 2032.
Published Date: 2026-02-11
Pages: 117
USD 2900.00
(Single User License)
The global Implantable Neurostimulation System market is projected to grow from US$ 5986 million in 2024 to US$ 11700 million by 2031, at a CAGR of 10.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 131
USD 4900.00
(Single User License)
The global market for Implantable Neurostimulation System was estimated to be worth US$ 5986 million in 2024 and is forecast to a readjusted size of US$ 11700 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 99
USD 3950.00
(Single User License)
The global market for Implantable Neurostimulation System was valued at US$ 5986 million in the year 2024 and is projected to reach a revised size of US$ 11700 million by 2031, growing at a CAGR of 10.2% during the forecast period.
Published Date: 2025-02-14
Pages: 78
USD 2900.00
(Single User License)
The global market for Implantable Neurostimulation System was estimated to be worth US$ 5438 million in 2023 and is forecast to a readjusted size of US$ 10720 million by 2030 with a CAGR of 10.2% during the forecast period 2024-2030.
Published Date: 2024-12-24
Pages: 94
USD 3950.00
(Single User License)
The global Implantable Neurostimulation System revenue was US$ 5438 million in 2023 and is forecast to a readjusted size of US$ 10720 million by 2030 with a CAGR of 10.2% during the review period (2024-2030).
Published Date: 2024-12-24
Pages: 101
USD 4350.00
(Single User License)
The global market for Implantable Neurostimulation System was valued at US$ 5438 million in the year 2023 and is projected to reach a revised size of US$ 10720 million by 2030, growing at a CAGR of 10.2% during the forecast period.
Published Date: 2024-12-24
Pages: 83
USD 2900.00
(Single User License)
Valued at US$ 5986 million in 2024, the global Implantable Neurostimulation System market is forecast to reach US$ 10720 million by 2030, at a CAGR of 10.2% during the forecast period.
Published Date: 2024-12-24
Pages: 130
USD 4900.00
(Single User License)
Implantable neurostimulation system are implantable, programmable medical devices that deliver electrical stimulation to specific parts of the patient's brain, spinal cord or peripheral nervous system to help treat various conditions, including chronic pain, movement disorders, epilepsy and Parkinson's disease.
Published Date: 2024-01-12
Pages: 122
USD 3950.00
(Single User License)
The global market for Implantable Neurostimulation System was estimated to be worth US$ 6536 million in 2025 and is projected to reach US$ 12780 million, growing at a CAGR of 10.2% from 2026 to 2032.
Published: 2026-02-11
Pages: 91
The global Implantable Neurostimulation System market was valued at US$ 6536 million in 2025 and is anticipated to reach US$ 12780 million by 2032, at a CAGR of 10.2% from 2026 to 2032.
Published: 2026-02-11
Pages: 117
The global Implantable Neurostimulation System market is projected to grow from US$ 5986 million in 2024 to US$ 11700 million by 2031, at a CAGR of 10.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 131
The global market for Implantable Neurostimulation System was estimated to be worth US$ 5986 million in 2024 and is forecast to a readjusted size of US$ 11700 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 99
The global market for Implantable Neurostimulation System was valued at US$ 5986 million in the year 2024 and is projected to reach a revised size of US$ 11700 million by 2031, growing at a CAGR of 10.2% during the forecast period.
Published: 2025-02-14
Pages: 78
The global market for Implantable Neurostimulation System was estimated to be worth US$ 5438 million in 2023 and is forecast to a readjusted size of US$ 10720 million by 2030 with a CAGR of 10.2% during the forecast period 2024-2030.
Published: 2024-12-24
Pages: 94
The global Implantable Neurostimulation System revenue was US$ 5438 million in 2023 and is forecast to a readjusted size of US$ 10720 million by 2030 with a CAGR of 10.2% during the review period (2024-2030).
Published: 2024-12-24
Pages: 101
The global market for Implantable Neurostimulation System was valued at US$ 5438 million in the year 2023 and is projected to reach a revised size of US$ 10720 million by 2030, growing at a CAGR of 10.2% during the forecast period.
Published: 2024-12-24
Pages: 83
Valued at US$ 5986 million in 2024, the global Implantable Neurostimulation System market is forecast to reach US$ 10720 million by 2030, at a CAGR of 10.2% during the forecast period.
Published: 2024-12-24
Pages: 130
Implantable neurostimulation system are implantable, programmable medical devices that deliver electrical stimulation to specific parts of the patient's brain, spinal cord or peripheral nervous system to help treat various conditions, including chronic pain, movement disorders, epilepsy and Parkinson's disease.
Published: 2024-01-12
Pages: 122
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now